[1] 张辉,雷汉飞,黄德亮,等.鼻咽癌放疗诱发肿瘤-附4例报道[J].肿瘤防治杂志,2001,8(3):333-4. [2] 吴秋良,陈秀芬,赵美卿,等.34例鼻咽放疗后继发癌临床病理分析[J].现代医学仪器与应用,2001,13(4):4-5. [3] Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned IMRT for head-and-neck cancer[J]. Int J Radiat Oncol Biol Phys, 2004, 58(3):663-73. [4] Chao KS,Ozyigit G, Thorsdad WL. Toxicity profile of IMRT for head and neck carcinoma and potential role of amifostine[J]. Semin Oncol, 2003, 30(1):101-8. [5] Lin A, Kim HM, Terrell JE, et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study[J]. Int J Radiat Oncol Biol Phys, 2003, 57(1): 61-70. [6] David F, Paul G., Arthur B. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy[J].Int J Radiat Oncol Biol Phys, 1997, 38(3): 667-72. [7] Eric J, Hall D, Wu C. Radiation-induced second cancers: the impact of 3D-CRT and IMRT[J]. Int J Radiat Oncol Biol Phys, 2003, 56(1): 83-8. [8] 孙全富,秋叶澄伯,陶祖范,等.阳江天然放射性高本底辐射慢性照射与实体癌超额危险[J].中华放射医学与防护杂志,2002,22(1):51-4.Sun QF, AKIBA Suminori, Tao ZF, et al. Excess relative risk for solid cancer mortality during prolonged exposure to high background natural radiation in Yangjiang area of China[J]. Chin J Radiol Med Prot, 2002, 22.(1): 51-4. [9] Williams PC, Hounsel AR. X-ray leakage considerations for IMRT[J]. Br J Radiol, 2001, 74(8): 98-102. |